Ledger.Open graph →
SEC Form D · Amendment · filed July 21, 2015

PhaseBio Pharmaceuticals Inc

Offering
$42.0M
Sold
$21.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Malvern, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Guy K. Fish · Malvern, PADirectorClay Thorp · Malvern, PADirectorRobert K. Ingram · Malvern, PADirectorAsish K. Xavier · Malvern, PADirectorJonathan Mow · Malvern, PAExec · DirectorJames K. Barrett · Malvern, PADirectorJustin K. Klein · Malvern, PADirectorAshutosh Chilkoti · Malvern, PADirectorMichael K. Gutch · Malvern, PADirectorJoel Sussman · Malvern, PAExecShawn R. Gensch · Burnsville, MNDirectorRichard E. Perlman · Irvine, CADirectorRichard C. Nordvold · Burnsville, MNDirectorJose Revuelta · Irvine, CAExec · DirectorJames K. Price · Irvine, CADirectorLisa M. Lavin · Burnsville, MNDirectorCraig Thiry · Irvine, CAExec · DirectorPeter S. Pettit · Atlanta, GADirectorWanda R. Morgan · Atlanta, GADirectorBarry L. Boniface · Atlanta, GAExec · DirectorBart A. Mclean · Atlanta, GADirectorRyan C. Leach · Atlanta, GADirectorMichael D. Long · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗